Incidence, risk factors, and outcomes of Panton-Valentine leukocidin-positive methicillin-susceptible staphylococcus aureus infections in Auckland, New Zealand

Journal of Clinical Microbiology

Volumn 48, Issue 10, 2010, Pages 3470-3474

  Muttaiyah, S ^a   Coombs, G ^b   Pandey, S ^a   Reed, P ^c   Ritchie, S ^d   Lennon, D ^d   Roberts, S ^a  

^a AUCKLAND CITY HOSPITAL   (New Zealand)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c STARSHIP CHILDREN S HOSPITAL   (New Zealand)

^d UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

PANTON VALENTINE LEUKOCIDIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTEREMIA; BACTERIAL STRAIN; BACTERIUM ISOLATE; BONE INFECTION; CATHETER INFECTION; CHILD; CONTROLLED STUDY; ENDOCARDITIS; ETHNICITY; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; NONHUMAN; PNEUMONIA; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD; SKIN INFECTION; SOFT TISSUE INFECTION; SURGICAL INFECTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BACTERIAL TOXINS; CARRIER STATE; CHILD; CHILD, PRESCHOOL; DNA, BACTERIAL; EXOTOXINS; FEMALE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; LEUKOCIDINS; MALE; METHICILLIN; MIDDLE AGED; NEW ZEALAND; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TREATMENT OUTCOME; VIRULENCE FACTORS; YOUNG ADULT;

METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS AUREUS;

EID: 77957781841     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00911-10     Document Type: Article

References (29)

1. Australian Council of Healthcare Standards. 2005. Infection control indicators: clinical indicator users' manual, version 3. Australian Council of Healthcare Standards, Sydney, Australia.
2. Baker, M., A. McNicholas, N. Garrett, N. Jones, J. Stewart, V. Koberstein, and D. Lennon. 2000. Household crowding a major risk factor for epidemic meningococcal disease in Auckland children. Pediatr. Infect. Dis. J. 19:983-990.
3. Bocchini, C. E., K. G. Hulten, E. O. Mason, Jr., B. E. Gonzalez, W. A. Hammerman, and S. L. Kaplan. 2006. Panton-Valentine leukocidin genes are associated with enhanced inflammatory response and local disease in acute hematogenous Staphylococcus aureus osteomyelitis in children. Pediatrics 117:433-440.
4. Boyle-Vavra, S., and R. S. Daum. 2007. Community-acquired methicillin-resistant S. aureus: the role of Panton-Valentine leukocidin. Lab. Invest. 87:3-9.
5. Cheung, A. S., C. A. Aboltins, J. R. Daffy, and P. A. Stanley. 2008. Necrotizing pneumonia due to Panton-Valentine leukocidin-positive methicillin-sensitive Staphylococcus aureus. Med. J. Aust. 188:373.
6. Crémieux, A. C., O. Dumitrescu, G. Lina, C. Vallee, J. M. Côté, M. Muffat-Joly, T. Lilin, J. Etienne, F. Vandenesch, and A. Saleh-Mghir. 2009. Panton-Valentine leukocidin enhances the severity of community-associated methicillin-resistant Staphylococcus aureus rabbit osteomyelitis. PLoS One 4:e7204.
7. Cribier, B., G. Prévost, and P. Couppie. 1992. Staphylococcus aureus leukocidin: a new virulence factor in cutaneous infections? An epidemiological and experimental study. Dermatology 185(3):175-180.
8. Durack, D. T., A. S. Lukes, and D. K. Bright. 1994. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service. Am. J. Med. 96:200-209.
9. Enright, M. C., N. P. Day, C. E. Davies, S. J. Peacock, and B. G. Spratt. 2000. Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. J. Clin. Microbiol. 38:1008-1015.
10. Feil, E. J., J. E. Cooper, H. Grundmann, D. A. Robinson, M. C. Enright, T. Berendt, S. J. Peacock, J. M. Smith, M. Murphy, B. G. Spratt, C. E. Moore, and N. P. Day. 2003. How clonal is Staphylococcus aureus? J. Bacteriol. 185:3307-3316.
11. Gillet, Y., B. Issartel, and P. Vanhems. 2002. Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotizing pneumonia in young immunocompetent patients. Lancet 359:753-759. (Pubitemid 34215075)
12. Hill, P. C., M. Birch, S. Chambers, D. Drinkovic, R. B. Ellis-Pegler, R. Everts, D. Murdoch, S. Pottumarthy, S. A. Roberts, C. Swager, S. L. Taylor, M. G. Thomas, C. G. Wong, and A. J. Morris. 2001. Prospective study of 424 cases of Staphylococcus aureus bacteraemia: determination of factors affecting incidence and mortality. Intern. Med. J. 31:97-103.
13. Hsu, L. Y., T. H. Koh, A. Kurup, J. Low, M. P. Chlebicki, and B. H. Tan. 2005. High incidence of Panton-Valentine leukocidin-producing Staphylococcus aureus in a tertiary care public hospital in Singapore. Clin. Infect. Dis. 40:486-489.
14. Jahamy, H., R. Ganga, B. Al Raiy, S. Shemes, V. Nagappan, M. Sharma, K. Riederer, and R. Khatib. 2008. Staphylococcus aureus skin/soft-tissue infections: the impact of SCCmec type and Panton-Valentine leukocidin. Scand. J. Infect. Dis. 40:601-606.
15. Kalka-Moll, W. M., J. C. Lee, M. Fabri, and H. Seifert. 2008. Intrafamilial outbreak of subcutaneous abscesses caused by PVL-positive methicillin-sensitive Staphylococcus aureus. J. Infect. 57:278-280.
16. Lesens, O., C. Methlin, and Y. Hansmann. 2003. Role of co-morbidity in mortality related to S. aureus bacteremia: a prospective study using the Charlson weighted index of co-morbidity. Infect. Control Hosp. Epidemiol. 24:890-896.
17. Lina, G., Y. Piémont, F. Godail-Gamot, M. Bes, M. O. Peter, V. Gauduchon, F. Vandenesch, and J. Etienne. 1999. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. J. Clin. Infect. Dis. 29:1128-1132.
18. Löffler, B., M. Hussain, M. Grundmeier, M. Brück, D. Holzinger, G. Varga, J. Roth, B. C. Kahl, R. A. Proctor, and G. Peters. 2010. Staphylococcus aureus Panton-Valentine leukocidin is a very potent cytotoxic factor for human neutrophils. PLoS Pathog. 6:e1000715.
19. Lowy, F. D., A. E. Aiello, M. Bhat, V. D. Johnson-Lawrence, M. H. Lee, E. Burrell, L. N. Wright, G. Vasquez, and E. L. Larson. 2007. Staphylococcus aureus colonization and infection in New York State prisons. J. Infect. Dis. 196:911-918.
20. McDonald, R. R., N. A. Antonishyn, T. Hansen, L. A. Snook, E. Nagle, M. R. Mulvey, P. N. Levett, and G. B. Horsman. 2005. Development of a triplex real-time PCR assay for detection of Panton-Valentine leukocidin toxin genes in clinical isolates of methicillin-resistant Staphylococcus aureus. J. Clin. Microbiol. 43:6147-6149.
21. Munckhof, W. J., G. R. Nimmo, J. Carney, J. M. Schooneveldt, F. Huygens, J. Inman-Bamber, E. Tong, A. Morton, and P. Giffard. 2008. Methicillin- susceptible, non-multiresistant methicillin-resistant and multiresistant methicillin-resistant Staphylococcus aureus infections: a clinical, epidemiological and microbiological comparative study. Eur. J. Clin. Microbiol. Infect. Dis. 27:355-364.
22. Robinson, D. A., A. M. Kearns, A. Holmes, D. Morrison, H. Grundmann, G. Edwards, F. G. O'Brien, F. C. Tenover, L. K. McDougal, A. B. Monk, and M. C. Enright. 2005. Re-emergence of early pandemic Staphylococcus aureus as a community-acquired meticillin-resistant clone. Lancet 365:1256-1258.
23. Salmond, C., P. Crampton, and J. Atkinson. 2007. NZDep2006 index of deprivation. Department of Public Health, University of Otago Wellington, Wellington, New Zealand.
24. Statistics New Zealand. 2 October 2009, accession date. 2006 census of populations and dwellings. District Health Board Area summary tables. http://www.stats.govt.nz/Census/about-2006-census/district-health-board -area-summary-tables.aspx. Statistics New Zealand, Auckland, New Zealand.
25. Tristan, A., M. Bes, H. Meugnier, G. Lina, B. Bozdogan, P. Courvalin, M. E. Reverdy, M. C. Enright, F. Vandenesch, and J. Etienne. 2007. Global distribution of Panton-Valentine leukocidin-positive methicillin-resistant Staphylococcus aureus, 2006. Emerg. Infect. Dis. 13:594-600.
26. Vorobieva, V., T. Bazhukova, A. M. Hanssen, D. A. Caugant, N. Semenova, B. C. Haldorsen, G. S. Simonsen, and A. Sundsfjord. 2008. Clinical isolates of Staphylococcus aureus from the Arkhangelsk region, Russia: antimicrobial susceptibility, molecular epidemiology, and distribution of Panton-Valentine leukocidin genes. APMIS 116:877-887.
27. Ward, P. D., and W. H. Turner. 1980. Identification of staphylococcal Panton-Valentine leukocidin as a potent dermonecrotic toxin. Infect. Immun. 28:393-397.
28. Wertheim, H. F., D. C. Melles, M. C. Vos, W. van Leeuwen, A. van Belkum, H. A. Verbrugh, and J. L. Nouwen. 2005. The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect. Dis. 5:751-762.
29. Yu, F., Z. Chen, C. Liu, X. Zhang, X. Lin, S. Chi, T. Zhou, Z. Chen, and X. Chen. 2008. Prevalence of Staphylococcus aureus carrying Panton-Valentine leukocidin genes among isolates from hospitalised patients in China. Clin. Microbiol. Infect. 14:381-384.